Cargando…

Biomarker-based risk prediction for the onset of neuroinflammation in X-linked adrenoleukodystrophy

BACKGROUND: X-linked adrenoleukodystrophy (X-ALD) is highly variable, ranging from slowly progressive adrenomyeloneuropathy to severe brain demyelination and inflammation (cerebral ALD, CALD) affecting males with childhood peak onset. Risk models integrating blood-based biomarkers to indicate CALD o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weinhofer, Isabelle, Rommer, Paulus, Gleiss, Andreas, Ponleitner, Markus, Zierfuss, Bettina, Waidhofer-Söllner, Petra, Fourcade, Stéphane, Grabmeier-Pfistershammer, Katharina, Reinert, Marie-Christine, Göpfert, Jens, Heine, Anne, Yska, Hemmo A.F., Casasnovas, Carlos, Cantarín, Verónica, Bergner, Caroline G., Mallack, Eric, Forss-Petter, Sonja, Aubourg, Patrick, Bley, Annette, Engelen, Marc, Eichler, Florian, Lund, Troy C., Pujol, Aurora, Köhler, Wolfgang, Kühl, Jörn-Sven, Berger, Johannes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497986/ https://www.ncbi.nlm.nih.gov/pubmed/37683329 http://dx.doi.org/10.1016/j.ebiom.2023.104781

Ejemplares similares

Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy
por: Weinhofer, Isabelle, et al.
Publicado: (2021)

Attitudes of Patients with Adrenoleukodystrophy towards Sex-Specific Newborn Screening
por: Yska, Hemmo A. F., et al.
Publicado: (2023)

Saturated very long-chain fatty acids regulate macrophage plasticity and invasiveness
por: Zierfuss, Bettina, et al.
Publicado: (2022)

Vorinostat in the acute neuroinflammatory form of X‐linked adrenoleukodystrophy
por: Zierfuss, Bettina, et al.
Publicado: (2020)

FcγR requirements and costimulatory capacity of Urelumab, Utomilumab, and Varlilumab
por: Leitner, Judith, et al.
Publicado: (2023)

Impaired plasticity of macrophages in X-linked adrenoleukodystrophy
por: Weinhofer, Isabelle, et al.
Publicado: (2018)

Pathophysiology of X-linked adrenoleukodystrophy()
por: Berger, J., et al.
Publicado: (2014)

BTLA inhibition has a dominant role in the cis-complex of BTLA and HVEM
por: Battin, Claire, et al.
Publicado: (2022)

Structure and Function of the ABCD1 Variant Database: 20 Years, 940 Pathogenic Variants, and 3400 Cases of Adrenoleukodystrophy
por: Mallack, Eric J., et al.
Publicado: (2022)

ABCD1 Transporter Deficiency Results in Altered Cholesterol Homeostasis
por: Buda, Agnieszka, et al.
Publicado: (2023)

Evaluation of Retinoids for Induction of the Redundant Gene ABCD2 as an Alternative Treatment Option in X-Linked Adrenoleukodystrophy
por: Weber, Franziska D., et al.
Publicado: (2014)

CD1 Gene Polymorphisms and Phenotypic Variability in X-Linked Adrenoleukodystrophy
por: Barbier, Mathieu, et al.
Publicado: (2012)

Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents
por: Battin, Claire, et al.
Publicado: (2023)

Evolution of adrenoleukodystrophy model systems
por: Montoro, Roberto, et al.
Publicado: (2021)

Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy
por: Schlüter, Agatha, et al.
Publicado: (2012)

X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management
por: Engelen, Marc, et al.
Publicado: (2012)

Lack of Induction of RBD-Specific Neutralizing Antibodies despite Repeated Heterologous SARS-CoV-2 Vaccination Leading to Seroconversion and Establishment of T Cell-Specific Memory in a Patient in Remission of Multiple Myeloma
por: Kratzer, Bernhard, et al.
Publicado: (2022)

FRI433 Hypogonadism In Males With Adrenoleukodystrophy
por: Alcantara, Jonanlis Ramirez, et al.
Publicado: (2023)

Molecular Biomarkers for Adrenoleukodystrophy: An Unmet Need
por: Honey, Madison I. J., et al.
Publicado: (2021)

Bezafibrate for X-Linked Adrenoleukodystrophy
por: Engelen, Marc, et al.
Publicado: (2012)

Epigenomic signature of adrenoleukodystrophy predicts compromised oligodendrocyte differentiation
por: Schlüter, Agatha, et al.
Publicado: (2018)

International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy: A Consensus-Based Approach
por: Engelen, Marc, et al.
Publicado: (2022)

Self‐reported quality of life in symptomatic and asymptomatic women with X‐linked adrenoleukodystrophy
por: Schäfer, Lisa, et al.
Publicado: (2023)

Targeting foam cell formation in inflammatory brain diseases by the histone modifier MS‐275
por: Zierfuss, Bettina, et al.
Publicado: (2020)

Gait Difficulties and Postural Instability in Adrenoleukodystrophy
por: Godbole, Neha P., et al.
Publicado: (2021)

The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis
por: Wiesinger, Christoph, et al.
Publicado: (2015)

Postural Body Sway as Surrogate Outcome for Myelopathy in Adrenoleukodystrophy
por: van Ballegoij, Wouter J. C., et al.
Publicado: (2020)

Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation
por: Engelen, Marc, et al.
Publicado: (2012)

Childhood cerebral X-linked adrenoleukodystrophy with atypical neuroimaging abnormalities and a novel mutation
por: Muranjan, M, et al.
Publicado: (2018)

Disease progression in women with X-linked adrenoleukodystrophy is slow
por: Huffnagel, Irene C., et al.
Publicado: (2019)

Antioxidants Halt Axonal Degeneration in a Mouse Model of X-Adrenoleukodystrophy
por: López-Erauskin, Jone, et al.
Publicado: (2011)

Optical coherence tomography to measure the progression of myelopathy in adrenoleukodystrophy
por: van Ballegoij, Wouter J. C., et al.
Publicado: (2021)

Autophagy induction halts axonal degeneration in a mouse model of X-adrenoleukodystrophy
por: Launay, Nathalie, et al.
Publicado: (2014)

Beyond gait and balance: urinary and bowel dysfunction in X-linked adrenoleukodystrophy
por: Corre, Camille S., et al.
Publicado: (2021)

Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy
por: López-Erauskin, Jone, et al.
Publicado: (2012)

Spinal cord atrophy as a measure of severity of myelopathy in adrenoleukodystrophy
por: van de Stadt, Stephanie I. W., et al.
Publicado: (2020)

Childhood cerebral adrenoleukodystrophy
por: Mittal, Aliza, et al.
Publicado: (2014)

Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy
por: Martinović, Ksenija, et al.
Publicado: (2023)

Optical coherence tomography shows neuroretinal thinning in myelopathy of adrenoleukodystrophy
por: van Ballegoij, Wouter J. C., et al.
Publicado: (2019)

Magnetic resonance spectroscopy as marker for neurodegeneration in X-linked adrenoleukodystrophy
por: van de Stadt, Stephanie I.W., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ug7kikqbcrl9qo68mgrm32hr5n